MVA-Based H5N1 Vaccine Affords Cross-Clade Protection in Mice against Influenza A/H5N1 Viruses at Low Doses and after Single Immunization
Joost H. C. M. Kreijtz, Yasemin Suezer, Gerrie de Mutsert et al. · 2009
Read MVA-Based H5N1 Vaccine Affords Cross-Clade Protection in Mice against Influenza A/H5N1 Viruses at Low Doses and after Single Immunization by Joost H. C. M. Kreijtz, Yasemin Suezer, Gerrie de Mutsert et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0007790.txt.
Description
Joost Kreijtz and co-authors published a study in PLOS ONE in 2009. It tests a vaccine against H5N1 bird flu in mice. Human infections with H5N1, reported often since 2003, are frequently deadly. A pandemic strain could emerge from these viruses, so vaccines are wanted.
The vaccine uses a harmless carrier virus, MVA, fitted with H5N1 parts. A single immunization at low dose protected mice. Protection crossed clades, meaning it covered differing virus branches. Cross-clade cover at low dose is exactly what pandemic stockpiles need. The study supports MVA as a platform for bird flu vaccines.
Catalog record
| CREATOR | Joost H. C. M. Kreijtz, Yasemin Suezer, Gerrie de Mutsert et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007790